Microbial Age as a Driver of Inflammaging: Testing Whether Gut Microbiota Senescence Precedes and Predicts Host Neuroimmune Decline

Hypothesis

The gut microbiota possesses an intrinsic biological age that advances independently of host chronological age and drives inflammaging through microbial‑derived phenylacetic acid and associated senescence‑associated secretory phenotypes. This microbial age predicts loss of cholinergic neurons in the enteric nervous system, gut barrier leak, and downstream neurocognitive decline earlier than host‑based biomarkers.

Mechanistic Basis

Aged microbiota exhibit a metagenomic signature of decreased diversity, enrichment of pathobionts, and altered metabolic output that raises circulating phenylacetic acid ([1]). Phenylacetic acid acts as a danger‑associated molecular pattern, stimulating TLR2/4 on enteric glia and macrophages, which release IL‑1β and TNF‑α. These cytokines impair cholinergic neuron survival by reducing NAD⁺ levels and increasing oxidative stress, reproducing the ENS degeneration seen in aging ([2]). Simultaneously, microbial SASP factors amplify intestinal permeability, allowing bacterial products to reach the systemic circulation and fuel microglial activation in the brain. Thus, microbiota aging initiates a feed‑forward loop that accelerates host inflammaging.

Testable Predictions

1. Individuals with an elevated gut‑microbiota age (measured by a metagenomic clock) will show higher plasma phenylacetic acid, greater ENS cholinergic neuron loss, and poorer performance on memory and motor tasks, independent of their host age.
2. A 48‑hour intermittent fasting protocol administered twice weekly for 12 weeks will reduce microbial age, lower phenylacetic acid, preserve cholinergic neuron density, and improve cognitive scores compared with an isocaloric control diet.
3. Transplanting feces from young donors into aged recipients will reset microbial age and ameliorate ENS degeneration, whereas transplanting aged microbiota into young recipients will prematurely induce phenylacetic acid elevation and ENS loss.

Experimental Design

• Cohort: Recruit 180 participants aged 60-80, stratify by baseline microbial age (young‑like vs old‑like microbiota) using shotgun metagenomics and a published clock ([3]).
• Baseline: Measure plasma phenylacetic acid ([1]), ENS cholinergic neuron density via rectal biopsy immunostaining for ChAT, gut permeability (lactulose/mannitol ratio), and cognitive composite (MoCA + gait speed).
• Intervention: Randomize to (a) 48‑hour fast twice weekly, (b) time‑restricted feeding (10 h window) as control, (c) usual diet. Maintain for 12 weeks.
• Outcome: Repeat baseline measures at 6 and 12 weeks. Primary endpoint: change in microbial age. Secondary endpoints: phenylacetic acid, ChAT‑positive neuron density, permeability, cognition.
• Microbiota transplant sub‑study: In a parallel mouse experiment, transplant feces from old‑like vs young‑like human donors into germ‑free aged mice; assess phenylacetic acid, ENS histology, and neuroinflammation after 4 weeks.

Falsification: If microbial age does not predict phenylacetic acid or ENS loss, or if fasting fails to modify microbial age and downstream phenotypes, the hypothesis is refuted.

Implications

Confirming that microbiota senescence precedes host inflammaging would shift focus from host‑centric anti‑inflammatory strategies to microbiome rejuvenation—e.g., defined consortia, phage‑pathobiont reduction, or timed fasting—offering a mechanistic lever to break the gut‑brain inflammaging cycle.